15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Outbreak of Invasive Infections From Subtype emm26.3 Group A Streptococcus Among Homeless Adults—Anchorage, Alaska, 2016–2017

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="S1"> <!-- named anchor --> </a> <h5 class="section-title" id="d7328789e222">Background</h5> <p id="P1">In 2016, we detected an outbreak of group A <i>Streptococcus</i> (GAS) invasive infections among the estimated 1000 persons experiencing homelessness (PEH) in Anchorage, Alaska. We characterized the outbreak and implemented a mass antibiotic intervention at homeless service facilities. </p> </div><div class="section"> <a class="named-anchor" id="S2"> <!-- named anchor --> </a> <h5 class="section-title" id="d7328789e230">Methods</h5> <p id="P2">We identified cases through the Alaska GAS laboratory-based surveillance system. We conducted <i>emm</i>-typing, antimicrobial susceptibility testing, and whole genome sequencing (WGS) on all invasive isolates and compared medical record data of patients infected with <i>emm26.3</i> and other <i>emm</i> types. In February 2017, we offered PEH at six facilities in Anchorage a single dose of 1 gram of azithromycin. We collected oropharyngeal and non-intact skin swabs on a subset of participants concurrent with the intervention and 4 weeks afterward. </p> </div><div class="section"> <a class="named-anchor" id="S3"> <!-- named anchor --> </a> <h5 class="section-title" id="d7328789e244">Results</h5> <p id="P3">From July 2016–April 2017, we detected 42 invasive <i>emm26.3</i> cases in Anchorage, 35 of which were in PEH. The <i>emm26.3</i> isolates differed on average by only 2 single nucleotide polymorphisms. Compared to other <i>emm</i> types, infection with <i>emm26.3</i> was associated with cellulitis (odds ratio [OR] 2.5, p=0.04) and necrotizing fasciitis (OR 4.4, p=0.02). We dispensed antibiotics to 391 PEH. Colonization with <i>emm26.3</i> decreased from 4% of 277 at baseline to 1% of 287 at follow-up (p=0.05). Invasive GAS incidence decreased from 1.5 cases per 1000 PEH/week in the 6 weeks prior to the intervention to 0.2 cases per 1000 PEH/week in the 6 weeks after (p=0.01). </p> </div><div class="section"> <a class="named-anchor" id="S4"> <!-- named anchor --> </a> <h5 class="section-title" id="d7328789e264">Conclusions</h5> <p id="P4">In an invasive GAS outbreak in PEH in Anchorage, mass antibiotic administration was temporally associated with reduced invasive disease cases and colonization prevalence. </p> </div>

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.

          emm sequence typing is the most widely used method for defining group A streptococcal (GAS) strains, and has been applied to isolates in all regions of the world. We did a systematic review of the global distribution of GAS emm types. 102 articles and reports were included (38 081 isolates). Epidemiological data from high-income countries were predominant, with sparse data from low-income countries. The epidemiology of GAS disease in Africa and the Pacific region seems to be different from that in other regions, particularly high-income countries. In Africa and the Pacific, there were no dominant emm types, a higher diversity of emm types, and many of the common emm types in other parts of the world were less common (including emm 1, 4, 6, and 12). Our data have implications for the development of GAS vaccines. On the basis of the available data, the current formulation of the experimental multivalent emm vaccine would provide good coverage in high-income countries, particularly USA, Canada, and Europe, but poor coverage in Africa and the Pacific, and only average coverage in Asia and the Middle East.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005-2012.

            Invasive group A Streptococcus (GAS) infections are associated with significant morbidity and mortality rates. We report the epidemiology and trends of invasive GAS over 8 years of surveillance.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

              Streptococcus pyogenes ranks among the main causes of mortality from bacterial infections worldwide. Currently there is no vaccine to prevent diseases such as rheumatic heart disease and invasive streptococcal infection. The streptococcal M protein that is used as the substrate for epidemiological typing is both a virulence factor and a vaccine antigen. Over 220 variants of this protein have been described, making comparisons between proteins difficult, and hindering M protein-based vaccine development. A functional classification based on 48 emm-clusters containing closely related M proteins that share binding and structural properties is proposed. The need for a paradigm shift from type-specific immunity against S. pyogenes to emm-cluster based immunity for this bacterium should be further investigated. Implementation of this emm-cluster-based system as a standard typing scheme for S. pyogenes will facilitate the design of future studies of M protein function, streptococcal virulence, epidemiological surveillance, and vaccine development. © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
                Bookmark

                Author and article information

                Journal
                Clinical Infectious Diseases
                Oxford University Press (OUP)
                1058-4838
                1537-6591
                April 01 2018
                March 19 2018
                October 23 2017
                April 01 2018
                March 19 2018
                October 23 2017
                : 66
                : 7
                : 1068-1074
                Affiliations
                [1 ]Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska
                [2 ]Section of Epidemiology, Division of Public Health, Alaska Department of Health and Social Services, Anchorage, Atlanta, Georgia
                [3 ]Respiratory Disease Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
                Article
                10.1093/cid/cix921
                5862750
                29069346
                cb5baab2-aaa6-43a2-b71a-460fe890a393
                © 2017
                History

                Comments

                Comment on this article